• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT
Click for more information
3.03% 3.2¢

SYNTARA LIMITED

Market Cap $41.29M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Ann: Change in substantial holding 		10:10 6 1.4K
10:10 Last post  newB Comments Created with Sketch.  6  Views Created with Sketch.  1.4K 
SNT
Ann: Update - Notification regarding unquoted securities - SNT 		23/08/24 6 1.4K
23/08/24 Last post  NZ Trader Comments Created with Sketch.  6  Views Created with Sketch.  1.4K 
SNT
Chart 		22/08/24 1 367
22/08/24 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  367 
SNT
SNT - Media thread 		22/08/24 8 2.0K
22/08/24 Last post  NZ Trader Comments Created with Sketch.  8  Views Created with Sketch.  2.0K 
SNT
Ann: Notification of cessation of securities - SNT 		21/08/24 0 219
21/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  219 
SNT
Ann: Notice of General Meeting/Proxy Form 		20/08/24 1 423
20/08/24 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  423 
SNT
Syntara the science explained
2
19/08/24 69 21K
19/08/24 Last post  NZ Trader Comments Created with Sketch.  69  Views Created with Sketch.  21K 
SNT
Ann: Syntara appoints new CFO 		18/08/24 9 2.4K
18/08/24 Last post  newB Comments Created with Sketch.  9  Views Created with Sketch.  2.4K 

See All Discussions arrow Created with Sketch.

Timeline

Notification of cessation of securities - SNT
21 Aug 14:39
 
Notice of General Meeting/Proxy Form
20 Aug 11:12
 
Update - Notification regarding unquoted securities - SNT
16 Aug 11:33
 
Notification of cessation of securities - SNT
16 Aug 09:25
 
Proposed Issue of Securities to Chief Executive Officer
16 Aug 09:12
 
Notification regarding unquoted securities - SNT
16 Aug 09:09
 
View More arrow Created with Sketch.

Featured News

NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
(20min delay)
Last
3.2¢ 		Change
-0.001(3.03%) 		Mkt cap ! $41.29M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $92.34K 2.853M

Buyers (Bids)

No. Vol. Price($)
1 384 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 443289 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
3.2¢ 		  Change
-0.001 ( 3.03 %)
Open High Low Volume
3.3¢ 3.3¢ 3.2¢ 605932
Last updated 15.55pm 23/08/2024 ?
SNT (ASX) Chart

Top Stories

IPH raises $100M to buy up Canadian IP firm Bereskin & Parr

IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.

Featured News

NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.